home / stock / pmd / pmd news


PMD News and Press, Psychemedics Corporation From 07/22/19

Stock Information

Company Name: Psychemedics Corporation
Stock Symbol: PMD
Market: NASDAQ
Website: psychemedics.com

Menu

PMD PMD Quote PMD Short PMD News PMD Articles PMD Message Board
Get PMD Alerts

News, Short Squeeze, Breakout and More Instantly...

PMD - Psychemedics Is Attractively Priced But Remains Risky

Psychemedics ( PMD ) focuses on its patented hair-based drug-testing system. The drug and alcohol testing market is a $6 billion market that is expected to grow at a high single-digit rate in the coming years. The two general macro drivers behind the expectation include stricter legal environm...

PMD - Psychemedics: A Profitable Micro-Cap With Risks

By Felipe Bijit and Stefan Larsen Psychedemics Corporation ( PMD ), as might be expected from a micro-cap stock, has what we might consider a divided personality. On the one hand, the company offers the possibility of returns through its unique technology allowing for organic growth. On th...

PMD - Psychemedics: There Are Drivers

It probably doesn't happen very often - an investment thesis playing out exactly as planned. In fact, some advisors propose an investor's exit strategy is more important than their entrance strategy. Ironically though, most investors are probably not nearly as willing to admit when an investme...

PMD - FDA clears Psychemedics hair test for fentanyl

Psychemedics (NASDAQ: PMD ) announces that the FDA has cleared its test for the synthetic opioid fentanyl using hair samples. More news on: Psychemedics Corporation, Healthcare stocks news, Read more ...

PMD - Psychemedics Test for Fentanyl Detection Cleared by FDA

ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s first and only FDA-cleared hair test for Fentanyl, a major killer increasingly fou...

PMD - Psychemedics reports Q1 results

Psychemedics (NASDAQ: PMD ): Q1 GAAP EPS of $0.11. More news on: Psychemedics Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

PMD - Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend

ACTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2019.  The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of May 7,...

PMD - Psychemedics Makes The Speculative Buy List

Psychemedics ( PMD ) provides drug testing via hair analysis. This is an asset-light business that has resulted in this small-cap generating impressive free cash flow over the years. 2018 marked the third consecutive year of record revenue. Domestic revenue grew by 11%, which is slightly above...

PMD - New Psychemedics Offering Further Enhances Cocaine Detection

SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader in detecting drugs of abuse using hair analysis, today at the National Drug and Alcohol Screening Association (NDASA) Conference introduced the industry’s fir...

PMD - Midday movers and shakers

Gainers:  Document Security Systems (NYSEMKT: DSS ) +57% . Cool Holdings (NASDAQ: AWSM ) +38% . Fuwei Films (NASDAQ: FFHL ) +30% . China Rapid Finance (NYSE: XRF ) +23% . Ctrip.com International (NASDAQ: CTRP ) +21% . Aqua Metals (NASDAQ: AQMS ) +18% . BioHiTech Global (NASDAQ: ...

Previous 10 Next 10